Farther Finance Advisors, LLC Relmada Therapeutics, Inc. Transaction History
Farther Finance Advisors, LLC
- $6.63 Trillion
- Q3 2025
A detailed history of Farther Finance Advisors, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 838 shares of RLMD stock, worth $1,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
838Holding current value
$1,944% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLMD
# of Institutions
56Shares Held
5.42MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$1.72 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA619KShares$1.44 Million0.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$1.33 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$919,9120.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$844,6580.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $66.4M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...